Member access

4-Traders Homepage  >  Shares  >  Nyse  >  West Pharmaceutical Services Inc.    WST   US9553061055

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales1 1921 2661 3681 4201 4791 619
Operating income (EBITDA)193219248284306332
Operating profit (EBIT)118142162187203240
Pre-Tax Profit (EBT)92,7109----
Net income75,580,7112131150178
EPS ( $)1,081,151,571,792,022,46
Dividend per Share ( $)0,35-0,390,430,47-
Yield0,69%-0,78%0,86%0,94%-
Announcement Date02/16/2012
12:00pm
02/21/2013
12:15pm
02/20/2014
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt258-----
Finance------
Operating income (EBITDA)193219248284306332
Leverage
(Debt/EBITDA)
1,33x-----
Capital Expenditure95,4-----
Book Value Per Share (BVPS)------
Cash Flow per Share--3,09 $3,29 $3,46 $-
Announcement Date02/16/2012
12:00pm
02/21/2013
12:15pm
02/20/2014
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 3 540 M$ -
Entreprise Value (EV) - 3 540 M$
Valuation 2014e 2015e
PER (Price / EPS) 27,8x 24,7x
Capitalization / Revenue 2,49x 2,39x
EV / Revenue - -
EV / EBITDA - -
Yield (DPS / Price) 0,86% 0,94%
Price to book (Cours / BVPS) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 13,1% 13,7%
operating Leverage (Delta EBIT / Delta Sales) 3,97x 2,13x
Net Margin (Net Profit / Revenue) 9,21% 10,1%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 13,4% -
Rate of Dividend 24,0% 23,3%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   - -
Cash Flow / Sales (Taux d'autofinancement) 16,5% 16,6%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF